Normunity
PrivateLast Round
Series B
Jan 13, 2025
Est. Valuation
$500M
Total Funding Raised
$140M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Normunity is a biotechnology company that develops precision immuno-oncology therapies designed to restore the immune system's natural ability to identify and eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Normunity Comparables
Compare Normunity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 84% | |
| Merck | 81% | |
| EvolveImmune | 80% | |
Normunity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Oct 25, 2022 |
Key People
Founding team and executive leadership
Normunity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Connecticut Innovations | Series B |
| Taiho Ventures | Series B, Series A |
| Osage University Partners | Series B, Series A |
| Canaan Partners | Series B, Series A |
| Pfizer Ventures | Series B |
| Sanofi Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 40% MoM, from 1K to 1.5K.
- Feb 4, 2026
Will participate in the TD Cowen 46th Annual Health Care Conference.
Normunity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Normunity's valuation, stock price, and market status.